<?xml version='1.0' encoding='UTF-8'?>
<uniprot xmlns="http://uniprot.org/uniprot" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://uniprot.org/uniprot http://www.uniprot.org/support/docs/uniprot.xsd">
<entry dataset="Swiss-Prot" created="1997-11-01" modified="2016-03-16" version="172">
<accession>Q15582</accession>
<accession>D3DQB1</accession>
<accession>O14471</accession>
<accession>O14472</accession>
<accession>O14476</accession>
<accession>O43216</accession>
<accession>O43217</accession>
<accession>O43218</accession>
<accession>O43219</accession>
<accession>Q53XM1</accession>
<name>BGH3_HUMAN</name>
<protein>
<recommendedName>
<fullName>Transforming growth factor-beta-induced protein ig-h3</fullName>
<shortName>Beta ig-h3</shortName>
</recommendedName>
<alternativeName>
<fullName>Kerato-epithelin</fullName>
</alternativeName>
<alternativeName>
<fullName>RGD-containing collagen-associated protein</fullName>
<shortName>RGD-CAP</shortName>
</alternativeName>
</protein>
<gene>
<name type="primary">TGFBI</name>
<name type="synonym">BIGH3</name>
</gene>
<organism>
<name type="scientific">Homo sapiens</name>
<name type="common">Human</name>
<dbReference type="NCBI Taxonomy" id="9606"/>
<lineage>
<taxon>Eukaryota</taxon>
<taxon>Metazoa</taxon>
<taxon>Chordata</taxon>
<taxon>Craniata</taxon>
<taxon>Vertebrata</taxon>
<taxon>Euteleostomi</taxon>
<taxon>Mammalia</taxon>
<taxon>Eutheria</taxon>
<taxon>Euarchontoglires</taxon>
<taxon>Primates</taxon>
<taxon>Haplorrhini</taxon>
<taxon>Catarrhini</taxon>
<taxon>Hominidae</taxon>
<taxon>Homo</taxon>
</lineage>
</organism>
<reference key="1">
<citation type="journal article" date="1992" name="DNA Cell Biol." volume="11" first="511" last="522">
<title>cDNA cloning and sequence analysis of beta ig-h3, a novel gene induced in a human adenocarcinoma cell line after treatment with transforming growth factor-beta.</title>
<authorList>
<person name="Skonier J."/>
<person name="Neubauer M."/>
<person name="Madisen L."/>
<person name="Bennett K."/>
<person name="Plowman G.D."/>
<person name="Purchio A.F."/>
</authorList>
<dbReference type="PubMed" id="1388724"/>
<dbReference type="DOI" id="10.1089/dna.1992.11.511"/>
</citation>
<scope>NUCLEOTIDE SEQUENCE [MRNA]</scope>
</reference>
<reference key="2">
<citation type="journal article" date="1997" name="Nat. Genet." volume="15" first="247" last="251">
<title>Kerato-epithelin mutations in four 5q31-linked corneal dystrophies.</title>
<authorList>
<person name="Munier F.L."/>
<person name="Korvatska E."/>
<person name="Djemai A."/>
<person name="le Paslier D."/>
<person name="Zografos L."/>
<person name="Pescia G."/>
<person name="Schorderet D.F."/>
</authorList>
<dbReference type="PubMed" id="9054935"/>
<dbReference type="DOI" id="10.1038/ng0397-247"/>
</citation>
<scope>NUCLEOTIDE SEQUENCE [GENOMIC DNA]</scope>
<scope>VARIANTS CORNEAL DYSTROPHIES CYS-124; HIS-124; GLN-555 AND TRP-555</scope>
</reference>
<reference key="3">
<citation type="submission" date="2002-09" db="EMBL/GenBank/DDBJ databases">
<authorList>
<consortium name="NIEHS SNPs program"/>
</authorList>
</citation>
<scope>NUCLEOTIDE SEQUENCE [GENOMIC DNA]</scope>
<scope>VARIANT PHE-200</scope>
</reference>
<reference key="4">
<citation type="submission" date="2003-08" db="EMBL/GenBank/DDBJ databases">
<title>Cloning of human full-length CDSs in BD Creator(TM) system donor vector.</title>
<authorList>
<person name="Kalnine N."/>
<person name="Chen X."/>
<person name="Rolfs A."/>
<person name="Halleck A."/>
<person name="Hines L."/>
<person name="Eisenstein S."/>
<person name="Koundinya M."/>
<person name="Raphael J."/>
<person name="Moreira D."/>
<person name="Kelley T."/>
<person name="LaBaer J."/>
<person name="Lin Y."/>
<person name="Phelan M."/>
<person name="Farmer A."/>
</authorList>
</citation>
<scope>NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA]</scope>
</reference>
<reference key="5">
<citation type="journal article" date="2004" name="Nature" volume="431" first="268" last="274">
<title>The DNA sequence and comparative analysis of human chromosome 5.</title>
<authorList>
<person name="Schmutz J."/>
<person name="Martin J."/>
<person name="Terry A."/>
<person name="Couronne O."/>
<person name="Grimwood J."/>
<person name="Lowry S."/>
<person name="Gordon L.A."/>
<person name="Scott D."/>
<person name="Xie G."/>
<person name="Huang W."/>
<person name="Hellsten U."/>
<person name="Tran-Gyamfi M."/>
<person name="She X."/>
<person name="Prabhakar S."/>
<person name="Aerts A."/>
<person name="Altherr M."/>
<person name="Bajorek E."/>
<person name="Black S."/>
<person name="Branscomb E."/>
<person name="Caoile C."/>
<person name="Challacombe J.F."/>
<person name="Chan Y.M."/>
<person name="Denys M."/>
<person name="Detter J.C."/>
<person name="Escobar J."/>
<person name="Flowers D."/>
<person name="Fotopulos D."/>
<person name="Glavina T."/>
<person name="Gomez M."/>
<person name="Gonzales E."/>
<person name="Goodstein D."/>
<person name="Grigoriev I."/>
<person name="Groza M."/>
<person name="Hammon N."/>
<person name="Hawkins T."/>
<person name="Haydu L."/>
<person name="Israni S."/>
<person name="Jett J."/>
<person name="Kadner K."/>
<person name="Kimball H."/>
<person name="Kobayashi A."/>
<person name="Lopez F."/>
<person name="Lou Y."/>
<person name="Martinez D."/>
<person name="Medina C."/>
<person name="Morgan J."/>
<person name="Nandkeshwar R."/>
<person name="Noonan J.P."/>
<person name="Pitluck S."/>
<person name="Pollard M."/>
<person name="Predki P."/>
<person name="Priest J."/>
<person name="Ramirez L."/>
<person name="Retterer J."/>
<person name="Rodriguez A."/>
<person name="Rogers S."/>
<person name="Salamov A."/>
<person name="Salazar A."/>
<person name="Thayer N."/>
<person name="Tice H."/>
<person name="Tsai M."/>
<person name="Ustaszewska A."/>
<person name="Vo N."/>
<person name="Wheeler J."/>
<person name="Wu K."/>
<person name="Yang J."/>
<person name="Dickson M."/>
<person name="Cheng J.-F."/>
<person name="Eichler E.E."/>
<person name="Olsen A."/>
<person name="Pennacchio L.A."/>
<person name="Rokhsar D.S."/>
<person name="Richardson P."/>
<person name="Lucas S.M."/>
<person name="Myers R.M."/>
<person name="Rubin E.M."/>
</authorList>
<dbReference type="PubMed" id="15372022"/>
<dbReference type="DOI" id="10.1038/nature02919"/>
</citation>
<scope>NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA]</scope>
</reference>
<reference key="6">
<citation type="submission" date="2005-09" db="EMBL/GenBank/DDBJ databases">
<authorList>
<person name="Mural R.J."/>
<person name="Istrail S."/>
<person name="Sutton G.G."/>
<person name="Florea L."/>
<person name="Halpern A.L."/>
<person name="Mobarry C.M."/>
<person name="Lippert R."/>
<person name="Walenz B."/>
<person name="Shatkay H."/>
<person name="Dew I."/>
<person name="Miller J.R."/>
<person name="Flanigan M.J."/>
<person name="Edwards N.J."/>
<person name="Bolanos R."/>
<person name="Fasulo D."/>
<person name="Halldorsson B.V."/>
<person name="Hannenhalli S."/>
<person name="Turner R."/>
<person name="Yooseph S."/>
<person name="Lu F."/>
<person name="Nusskern D.R."/>
<person name="Shue B.C."/>
<person name="Zheng X.H."/>
<person name="Zhong F."/>
<person name="Delcher A.L."/>
<person name="Huson D.H."/>
<person name="Kravitz S.A."/>
<person name="Mouchard L."/>
<person name="Reinert K."/>
<person name="Remington K.A."/>
<person name="Clark A.G."/>
<person name="Waterman M.S."/>
<person name="Eichler E.E."/>
<person name="Adams M.D."/>
<person name="Hunkapiller M.W."/>
<person name="Myers E.W."/>
<person name="Venter J.C."/>
</authorList>
</citation>
<scope>NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA]</scope>
</reference>
<reference key="7">
<citation type="journal article" date="2004" name="Genome Res." volume="14" first="2121" last="2127">
<title>The status, quality, and expansion of the NIH full-length cDNA project: the Mammalian Gene Collection (MGC).</title>
<authorList>
<consortium name="The MGC Project Team"/>
</authorList>
<dbReference type="PubMed" id="15489334"/>
<dbReference type="DOI" id="10.1101/gr.2596504"/>
</citation>
<scope>NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA]</scope>
<source>
<tissue>Kidney</tissue>
</source>
</reference>
<reference key="8">
<citation type="journal article" date="1994" name="J. Cell. Physiol." volume="160" first="511" last="521">
<title>cDNA from human ocular ciliary epithelium homologous to beta ig-h3 is preferentially expressed as an extracellular protein in the corneal epithelium.</title>
<authorList>
<person name="Escribano J."/>
<person name="Hernando N."/>
<person name="Ghosh S."/>
<person name="Crabb J."/>
<person name="Coca-Prados M."/>
</authorList>
<dbReference type="PubMed" id="8077289"/>
<dbReference type="DOI" id="10.1002/jcp.1041600314"/>
</citation>
<scope>TISSUE SPECIFICITY</scope>
</reference>
<reference key="9">
<citation type="journal article" date="2001" name="J. Hum. Genet." volume="46" first="431" last="435">
<title>Corneal dystrophies in Japan.</title>
<authorList>
<person name="Fujiki K."/>
<person name="Nakayasu K."/>
<person name="Kanai A."/>
</authorList>
<dbReference type="PubMed" id="11501939"/>
<dbReference type="DOI" id="10.1007/s100380170041"/>
</citation>
<scope>REVIEW ON VARIANTS CORNEAL DYSTROPHIES</scope>
</reference>
<reference key="10">
<citation type="journal article" date="2014" name="J. Proteomics" volume="96" first="253" last="262">
<title>An enzyme assisted RP-RPLC approach for in-depth analysis of human liver phosphoproteome.</title>
<authorList>
<person name="Bian Y."/>
<person name="Song C."/>
<person name="Cheng K."/>
<person name="Dong M."/>
<person name="Wang F."/>
<person name="Huang J."/>
<person name="Sun D."/>
<person name="Wang L."/>
<person name="Ye M."/>
<person name="Zou H."/>
</authorList>
<dbReference type="PubMed" id="24275569"/>
<dbReference type="DOI" id="10.1016/j.jprot.2013.11.014"/>
</citation>
<scope>PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-37</scope>
<scope>IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS]</scope>
<source>
<tissue>Liver</tissue>
</source>
</reference>
<reference key="11">
<citation type="submission" date="2006-01" db="PDB data bank">
<title>Solution structure of the FAS1 domain of human transforming growth factor-beta induced protein IG-H3.</title>
<authorList>
<consortium name="RIKEN structural genomics initiative (RSGI)"/>
</authorList>
</citation>
<scope>STRUCTURE BY NMR OF 502-634</scope>
</reference>
<reference key="12">
<citation type="journal article" date="1998" name="Am. J. Hum. Genet." volume="62" first="320" last="324">
<title>Mutation hot spots in 5q31-linked corneal dystrophies.</title>
<authorList>
<person name="Korvatska E."/>
<person name="Munier F.L."/>
<person name="Djemai A."/>
<person name="Wang M.X."/>
<person name="Frueh B."/>
<person name="Chiou A.G.-Y."/>
<person name="Uffer S."/>
<person name="Ballestrazzi E."/>
<person name="Braunstein R.E."/>
<person name="Forster R.K."/>
<person name="Culbertson W.W."/>
<person name="Boman H."/>
<person name="Zografos L."/>
<person name="Schorderet D.F."/>
</authorList>
<dbReference type="PubMed" id="9463327"/>
<dbReference type="DOI" id="10.1086/301720"/>
</citation>
<scope>VARIANTS CORNEAL DYSTROPHIES CYS-124; HIS-124; GLN-555 AND TRP-555</scope>
</reference>
<reference key="13">
<citation type="journal article" date="1998" name="Am. J. Hum. Genet." volume="62" first="719" last="722">
<title>A kerato-epithelin (beta-ig-h3) mutation in lattice corneal dystrophy type IIIA.</title>
<authorList>
<person name="Yamamoto S."/>
<person name="Okada M."/>
<person name="Tsujikawa M."/>
<person name="Shimomura Y."/>
<person name="Nishida K."/>
<person name="Inoue Y."/>
<person name="Watanabe H."/>
<person name="Maeda N."/>
<person name="Kurahashi H."/>
<person name="Kinoshita S."/>
<person name="Nakamura Y."/>
<person name="Tano Y."/>
</authorList>
<dbReference type="PubMed" id="9497262"/>
<dbReference type="DOI" id="10.1086/301765"/>
</citation>
<scope>VARIANT CDL3A THR-501</scope>
</reference>
<reference key="14">
<citation type="journal article" date="1998" name="Am. J. Ophthalmol." volume="126" first="535" last="542">
<title>Two distinct kerato-epithelin mutations in Reis-Bucklers corneal dystrophy.</title>
<authorList>
<person name="Okada M."/>
<person name="Yamamoto S."/>
<person name="Tsujikawa M."/>
<person name="Watanabe H."/>
<person name="Inoue Y."/>
<person name="Maeda N."/>
<person name="Shimomura Y."/>
<person name="Nishida K."/>
<person name="Quantock A.J."/>
<person name="Kinoshita S."/>
<person name="Tano Y."/>
</authorList>
<dbReference type="PubMed" id="9780098"/>
<dbReference type="DOI" id="10.1016/S0002-9394(98)00135-4"/>
</citation>
<scope>VARIANT CDRB LEU-124</scope>
</reference>
<reference key="15">
<citation type="journal article" date="1998" name="Hum. Genet." volume="103" first="286" last="289">
<title>A new L527R mutation of the betaIGH3 gene in patients with lattice corneal dystrophy with deep stromal opacities.</title>
<authorList>
<person name="Fujiki K."/>
<person name="Hotta Y."/>
<person name="Nakayasu K."/>
<person name="Yokoyama T."/>
<person name="Takano T."/>
<person name="Yamaguchi T."/>
<person name="Kanai A."/>
</authorList>
<dbReference type="PubMed" id="9799082"/>
<dbReference type="DOI" id="10.1007/s004390050818"/>
</citation>
<scope>VARIANT CDL1 ARG-527</scope>
</reference>
<reference key="16">
<citation type="journal article" date="1998" name="Hum. Mutat." volume="12" first="215" last="216">
<title>A common beta ig-h3 gene mutation (delta F540) in a large cohort of Sardinian Reis Buecklers' corneal dystrophy patients.</title>
<authorList>
<person name="Rozzo C."/>
<person name="Fossarello M."/>
<person name="Galleri G."/>
<person name="Sole G."/>
<person name="Serru A."/>
<person name="Orzalesi N."/>
<person name="Serra A."/>
<person name="Pirastu M."/>
</authorList>
<dbReference type="PubMed" id="10660331"/>
</citation>
<scope>VARIANT CDRB PHE-540 DEL</scope>
</reference>
<reference key="17">
<citation type="journal article" date="1999" name="Hum. Mutat." volume="14" first="126" last="132">
<title>Heterogeneity in granular corneal dystrophy: identification of three causative mutations in the TGFBI (BIGH3) gene-lessons for corneal amyloidogenesis.</title>
<authorList>
<person name="Stewart H.S."/>
<person name="Ridgway A.E."/>
<person name="Dixon M.J."/>
<person name="Bonshek R.E."/>
<person name="Parveen R."/>
<person name="Black G.C."/>
</authorList>
<dbReference type="PubMed" id="10425035"/>
<dbReference type="DOI" id="10.1002/(SICI)1098-1004(1999)14:2&lt;126::AID-HUMU4>3.0.CO;2-W"/>
</citation>
<scope>VARIANTS CORNEAL DYSTROPHIES HIS-124; SER-124 AND TRP-555</scope>
</reference>
<reference key="18">
<citation type="journal article" date="1999" name="Ophthalmology" volume="106" first="964" last="970">
<title>A mutation within exon 14 of the TGFBI (BIGH3) gene on chromosome 5q31 causes an asymmetric, late-onset form of lattice corneal dystrophy.</title>
<authorList>
<person name="Stewart H.S."/>
<person name="Black G.C."/>
<person name="Donnai D."/>
<person name="Bonshek R.E."/>
<person name="McCarthy J."/>
<person name="Morgan S."/>
<person name="Dixon M.J."/>
<person name="Ridgway A.A."/>
</authorList>
<dbReference type="PubMed" id="10328397"/>
<dbReference type="DOI" id="10.1016/S0161-6420(99)00539-4"/>
</citation>
<scope>VARIANTS CDL HIS-622 AND ARG-626</scope>
</reference>
<reference key="19">
<citation type="journal article" date="2000" name="Am. J. Ophthalmol." volume="130" first="516" last="517">
<title>Association of autosomal dominantly inherited corneal dystrophies with BIGH3 gene mutations in Japan.</title>
<authorList>
<person name="Mashima Y."/>
<person name="Yamamoto S."/>
<person name="Inoue Y."/>
<person name="Yamada M."/>
<person name="Konishi M."/>
<person name="Watanabe H."/>
<person name="Maeda N."/>
<person name="Shimomura Y."/>
<person name="Kinoshita S."/>
</authorList>
<dbReference type="PubMed" id="11024425"/>
<dbReference type="DOI" id="10.1016/S0002-9394(00)00571-7"/>
</citation>
<scope>VARIANTS CORNEAL DYSTROPHIES CYS-124; HIS-124; LEU-124; THR-501; ARG-527; SER-544; GLN-555 AND TRP-555</scope>
</reference>
<reference key="20">
<citation type="journal article" date="2000" name="Arch. Ophthalmol." volume="118" first="814" last="818">
<title>A novel variant of granular corneal dystrophy caused by association of 2 mutations in the TGFBI gene-R124L and deltaT125-deltaE126.</title>
<authorList>
<person name="Dighiero P."/>
<person name="Drunat S."/>
<person name="D'Hermies F."/>
<person name="Renard G."/>
<person name="Delpech M."/>
<person name="Valleix S."/>
</authorList>
<dbReference type="PubMed" id="10865320"/>
<dbReference type="DOI" id="10.1001/archopht.118.6.814"/>
</citation>
<scope>VARIANTS CORNEAL DYSTROPHIES LEU-124 AND 125-THR-GLU-126 DEL</scope>
</reference>
<reference key="21">
<citation type="journal article" date="2000" name="Br. J. Ophthalmol." volume="84" first="583" last="585">
<title>Corneal amyloidosis caused by Leu518Pro mutation of betaig-h3 gene.</title>
<authorList>
<person name="Hirano K."/>
<person name="Hotta Y."/>
<person name="Fujiki K."/>
<person name="Kanai A."/>
</authorList>
<dbReference type="PubMed" id="10837380"/>
<dbReference type="DOI" id="10.1136/bjo.84.6.583"/>
</citation>
<scope>VARIANT CDL1 PRO-518</scope>
</reference>
<reference key="22">
<citation type="journal article" date="2001" name="Cornea" volume="20" first="525" last="529">
<title>Late-onset form of lattice corneal dystrophy caused by Leu527Arg mutation of the TGFBI gene.</title>
<authorList>
<person name="Hirano K."/>
<person name="Hotta Y."/>
<person name="Nakamura M."/>
<person name="Fujiki K."/>
<person name="Kanai A."/>
<person name="Yamamoto N."/>
</authorList>
<dbReference type="PubMed" id="11413411"/>
<dbReference type="DOI" id="10.1097/00003226-200107000-00017"/>
</citation>
<scope>VARIANT CDL1 ARG-527</scope>
</reference>
<reference key="23">
<citation type="journal article" date="2001" name="Ophthalmology" volume="108" first="818" last="823">
<title>Histologic phenotype-genotype correlation of corneal dystrophies associated with eight distinct mutations in the TGFBI gene.</title>
<authorList>
<person name="Dighiero P."/>
<person name="Niel F."/>
<person name="Ellies P."/>
<person name="D'Hermies F."/>
<person name="Savoldelli M."/>
<person name="Renard G."/>
<person name="Delpech M."/>
<person name="Valleix S."/>
</authorList>
<dbReference type="PubMed" id="11297504"/>
<dbReference type="DOI" id="10.1016/S0161-6420(00)00662-X"/>
</citation>
<scope>VARIANTS CORNEAL DYSTROPHIES CYS-124; HIS-124; LEU-124; 125-THR-GLU-126 DEL; THR-546; GLN-555; TRP-555 AND ARG-626</scope>
</reference>
<reference key="24">
<citation type="journal article" date="2002" name="Invest. Ophthalmol. Vis. Sci." volume="43" first="949" last="954">
<title>BIGH3 mutation spectrum in corneal dystrophies.</title>
<authorList>
<person name="Munier F.L."/>
<person name="Frueh B.E."/>
<person name="Othenin-Girard P."/>
<person name="Uffer S."/>
<person name="Cousin P."/>
<person name="Wang M.X."/>
<person name="Heon E."/>
<person name="Black G.C.M."/>
<person name="Blasi M.A."/>
<person name="Balestrazzi E."/>
<person name="Lorenz B."/>
<person name="Escoto R."/>
<person name="Barraquer R."/>
<person name="Hoeltzenbein M."/>
<person name="Gloor B."/>
<person name="Fossarello M."/>
<person name="Singh A.D."/>
<person name="Arsenijevic Y."/>
<person name="Zografos L."/>
<person name="Schorderet D.F."/>
</authorList>
<dbReference type="PubMed" id="11923233"/>
</citation>
<scope>VARIANTS CORNEAL DYSTROPHIES CYS-124; HIS-124; SER-124; ARG-518; ARG-538; PHE-540 DEL; TRP-555; LYS-622; ASP-623; ARG-626; PRO-626 AND ASP-631</scope>
</reference>
<reference key="25">
<citation type="journal article" date="2003" name="Am. J. Ophthalmol." volume="136" first="872" last="878">
<title>A new mutation (Leu569Arg) within exon 13 of the TGFBI (BIGH3) gene causes lattice corneal dystrophy type I.</title>
<authorList>
<person name="Warren J.F."/>
<person name="Abbott R.L."/>
<person name="Yoon M.K."/>
<person name="Crawford J.B."/>
<person name="Spencer W.H."/>
<person name="Margolis T.P."/>
</authorList>
<dbReference type="PubMed" id="14597039"/>
<dbReference type="DOI" id="10.1016/S0002-9394(03)00541-5"/>
</citation>
<scope>VARIANT CDL1 ARG-569</scope>
</reference>
<reference key="26">
<citation type="journal article" date="2003" name="Jpn. J. Ophthalmol." volume="47" first="246" last="248">
<title>A novel mutation of the TGFBI gene found in a Vietnamese family with atypical granular corneal dystrophy.</title>
<authorList>
<person name="Ha N.T."/>
<person name="Cung le X."/>
<person name="Chau H.M."/>
<person name="Thanh T.K."/>
<person name="Fujiki K."/>
<person name="Murakami A."/>
<person name="Kanai A."/>
</authorList>
<dbReference type="PubMed" id="12782158"/>
<dbReference type="DOI" id="10.1016/S0021-5155(03)00019-4"/>
</citation>
<scope>VARIANT GRANULAR CORNEAL DYSTROPHY HIS-123</scope>
</reference>
<reference key="27">
<citation type="journal article" date="2004" name="Am. J. Ophthalmol." volume="138" first="772" last="781">
<title>Lattice corneal dystrophy associated with the Ala546Asp and Pro551Gln missense changes in the TGFBI gene.</title>
<authorList>
<person name="Aldave A.J."/>
<person name="Gutmark J.G."/>
<person name="Yellore V.S."/>
<person name="Affeldt J.A."/>
<person name="Meallet M.A."/>
<person name="Udar N."/>
<person name="Rao N.A."/>
<person name="Small K.W."/>
<person name="Klintworth G.K."/>
</authorList>
<dbReference type="PubMed" id="15531312"/>
<dbReference type="DOI" id="10.1016/j.ajo.2004.06.021"/>
</citation>
<scope>VARIANTS CDL1 ASP-546 AND GLN-551</scope>
</reference>
<reference key="28">
<citation type="journal article" date="2005" name="Invest. Ophthalmol. Vis. Sci." volume="46" first="121" last="125">
<title>TGFBI gene mutations causing lattice and granular corneal dystrophies in Indian patients.</title>
<authorList>
<person name="Chakravarthi S.V.V.K."/>
<person name="Kannabiran C."/>
<person name="Sridhar M.S."/>
<person name="Vemuganti G.K."/>
</authorList>
<dbReference type="PubMed" id="15623763"/>
<dbReference type="DOI" id="10.1167/iovs.04-0440"/>
</citation>
<scope>VARIANTS CDL1 CYS-124 AND ARG-626</scope>
<scope>VARIANT CDRB LEU-124</scope>
<scope>VARIANT CDGG1 TRP-555</scope>
<scope>VARIANTS LATTICE CORNEAL DYSTROPHY ASP-539; VAL-594 AND 624-VAL-VAL-625 DEL</scope>
<scope>VARIANT PHE-269</scope>
</reference>
<reference key="29">
<citation type="journal article" date="2005" name="Invest. Ophthalmol. Vis. Sci." volume="46" first="1133" last="1139">
<title>Hereditary lattice corneal dystrophy is associated with corneal amyloid deposits enclosing C-terminal fragments of keratoepithelin.</title>
<authorList>
<person name="Stix B."/>
<person name="Leber M."/>
<person name="Bingemer P."/>
<person name="Gross C."/>
<person name="Rueschoff J."/>
<person name="Faendrich M."/>
<person name="Schorderet D.F."/>
<person name="Vorwerk C.K."/>
<person name="Zacharias M."/>
<person name="Roessner A."/>
<person name="Roecken C."/>
</authorList>
<dbReference type="PubMed" id="15790870"/>
<dbReference type="DOI" id="10.1167/iovs.04-1319"/>
</citation>
<scope>VARIANT CDL3A SER-540</scope>
</reference>
<reference key="30">
<citation type="journal article" date="2005" name="Jpn. J. Ophthalmol." volume="49" first="84" last="88">
<title>Novel mutation (V505D) of the TGFBI gene found in a Chinese family with lattice corneal dystrophy, type I.</title>
<authorList>
<person name="Tian X."/>
<person name="Fujiki K."/>
<person name="Wang W."/>
<person name="Murakami A."/>
<person name="Xie P."/>
<person name="Kanai A."/>
<person name="Liu Z."/>
</authorList>
<dbReference type="PubMed" id="15838722"/>
<dbReference type="DOI" id="10.1007/s10384-004-0167-7"/>
</citation>
<scope>VARIANT CDL1 ASP-505</scope>
</reference>
<reference key="31">
<citation type="journal article" date="2006" name="Hum. Mutat." volume="27" first="553" last="557">
<title>A subset of patients with epithelial basement membrane corneal dystrophy have mutations in TGFBI/BIGH3.</title>
<authorList>
<person name="Boutboul S."/>
<person name="Black G.C.M."/>
<person name="Moore J.E."/>
<person name="Sinton J."/>
<person name="Menasche M."/>
<person name="Munier F.L."/>
<person name="Laroche L."/>
<person name="Abitbol M."/>
<person name="Schorderet D.F."/>
</authorList>
<dbReference type="PubMed" id="16652336"/>
<dbReference type="DOI" id="10.1002/humu.20331"/>
</citation>
<scope>VARIANTS EBMD ARG-509 AND SER-666</scope>
</reference>
<reference key="32">
<citation type="journal article" date="2006" name="Jpn. J. Ophthalmol." volume="50" first="403" last="408">
<title>A novel H572R mutation in the transforming growth factor-beta-induced gene in a Thai family with lattice corneal dystrophy type I.</title>
<authorList>
<person name="Atchaneeyasakul L.-O."/>
<person name="Appukuttan B."/>
<person name="Pingsuthiwong S."/>
<person name="Yenchitsomanus P.-T."/>
<person name="Trinavarat A."/>
<person name="Srisawat C."/>
</authorList>
<dbReference type="PubMed" id="17013691"/>
<dbReference type="DOI" id="10.1007/s10384-006-0357-6"/>
</citation>
<scope>VARIANT CDL1 ARG-572</scope>
</reference>
<reference key="33">
<citation type="journal article" date="2006" name="Mol. Vis." volume="12" first="142" last="146">
<title>Unilateral lattice corneal dystrophy associated with the novel His572del mutation in the TGFBI gene.</title>
<authorList>
<person name="Aldave A.J."/>
<person name="Rayner S.A."/>
<person name="Kim B.T."/>
<person name="Prechanond A."/>
<person name="Yellore V.S."/>
</authorList>
<dbReference type="PubMed" id="16541014"/>
</citation>
<scope>VARIANT CDL1 HIS-572 DEL</scope>
</reference>
<reference key="34">
<citation type="journal article" date="2006" name="Mol. Vis." volume="12" first="331" last="335">
<title>Expanding the mutational spectrum in TGFBI-linked corneal dystrophies: identification of a novel and unusual mutation (Val113Ile) in a family with granular dystrophy.</title>
<authorList>
<person name="Zenteno J.C."/>
<person name="Ramirez-Miranda A."/>
<person name="Santacruz-Valdes C."/>
<person name="Suarez-Sanchez R."/>
</authorList>
<dbReference type="PubMed" id="16636649"/>
</citation>
<scope>VARIANT GRANULAR CORNEAL DYSTROPHY ILE-113</scope>
</reference>
<comment type="function">
<text>Binds to type I, II, and IV collagens. This adhesion protein may play an important role in cell-collagen interactions. In cartilage, may be involved in endochondral bone formation.</text>
</comment>
<comment type="interaction">
<interactant intactId="EBI-10236573"/>
<interactant intactId="EBI-10175124">
<id>Q8IZU0</id>
<label>FAM9B</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>3</experiments>
</comment>
<comment type="subcellular location">
<subcellularLocation>
<location>Secreted</location>
<location>Extracellular space</location>
<location>Extracellular matrix</location>
</subcellularLocation>
<text>May be associated both with microfibrils and with the cell surface.</text>
</comment>
<comment type="tissue specificity">
<text evidence="28">Highly expressed in the corneal epithelium.</text>
</comment>
<comment type="induction">
<text>By TGFB1.</text>
</comment>
<comment type="PTM">
<text evidence="5">Gamma-carboxyglutamate residues are formed by vitamin K dependent carboxylation. These residues are essential for the binding of calcium (By similarity).</text>
</comment>
<comment type="disease" evidence="26">
<disease id="DI-01535">
<name>Corneal dystrophy, epithelial basement membrane</name>
<acronym>EBMD</acronym>
<description>A bilateral anterior corneal dystrophy characterized by grayish epithelial fingerprint lines, geographic map-like lines, and dots (or microcysts) on slit-lamp examination. Pathologic studies show abnormal, redundant basement membrane and intraepithelial lacunae filled with cellular debris.</description>
<dbReference type="MIM" id="121820"/>
</disease>
<text>The disease is caused by mutations affecting the gene represented in this entry.</text>
</comment>
<comment type="disease" evidence="21">
<disease id="DI-01427">
<name>Corneal dystrophy, Groenouw type 1</name>
<acronym>CDGG1</acronym>
<description>A rare form of stromal corneal dystrophy characterized by multiple small deposits in the superficial central corneal stroma, and progressive visual impairment.</description>
<dbReference type="MIM" id="121900"/>
</disease>
<text>The disease is caused by mutations affecting the gene represented in this entry.</text>
</comment>
<comment type="disease" evidence="12 16 19 20 21 23 24 27 33">
<disease id="DI-01428">
<name>Corneal dystrophy, lattice type 1</name>
<acronym>CDL1</acronym>
<description>A form of lattice corneal dystrophy, a class of inherited stromal amyloidoses characterized by pathognomonic branching lattice figures in the cornea. CDL1 is characterized by progressive visual impairment, and the presence of delicate, double-contoured, interdigitating, elongated deposits that form a reticular pattern in the corneal stroma. Systemic amyloidosis is absent. Recurrent corneal ulceration sometimes occurs.</description>
<dbReference type="MIM" id="122200"/>
</disease>
<text>The disease is caused by mutations affecting the gene represented in this entry.</text>
</comment>
<comment type="disease">
<disease id="DI-01429">
<name>Corneal dystrophy, Thiel-Behnke type</name>
<acronym>CDTB</acronym>
<description>A bilateral disorder of the cornea characterized by progressive honeycomb-like, subepithelial corneal opacities with recurrent erosions.</description>
<dbReference type="MIM" id="602082"/>
</disease>
<text>The disease is caused by mutations affecting the gene represented in this entry.</text>
</comment>
<comment type="disease" evidence="11 21 32">
<disease id="DI-02252">
<name>Corneal dystrophy, Reis-Bucklers type</name>
<acronym>CDRB</acronym>
<description>A bilateral disorder of the cornea characterized by intermittent attacks of ocular irritation, recurrent painful corneal erosions starting in childhood, corneal opacities in a geographic pattern at the level of the Bowman layer, and a progressive decrease of visual acuity. The lesions are primarily in Bowman membrane with secondary involvement of the epithelium and superficial part of the stroma. Bowman membrane is almost completely replaced by pathologic materials including disoriented collagen fibrils.</description>
<dbReference type="MIM" id="608470"/>
</disease>
<text>The disease is caused by mutations affecting the gene represented in this entry.</text>
</comment>
<comment type="disease" evidence="22 31">
<disease id="DI-01882">
<name>Corneal dystrophy, lattice type 3A</name>
<acronym>CDL3A</acronym>
<description>A form of lattice corneal dystrophy, a class of inherited stromal amyloidoses characterized by pathognomonic branching lattice figures in the cornea. CDL3A is characterized by decreased visual acuity, and the presence of thick, ropy branching lattice lines and accumulations of amyloid deposits in the corneal stroma. Systemic amyloidosis is absent. CDL3A clinically resembles to lattice corneal dystrophy type 3, but differs in that its age of onset is 70 to 90 years. It has an autosomal dominant inheritance pattern.</description>
<dbReference type="MIM" id="608471"/>
</disease>
<text>The disease is caused by mutations affecting the gene represented in this entry.</text>
</comment>
<comment type="disease">
<disease id="DI-01264">
<name>Corneal dystrophy, Avellino type</name>
<acronym>CDA</acronym>
<description>A corneal disease resulting in reduced visual acuity and characterized by gray, crumb-like granular deposits in the anterior third of the stroma in each corneal button. Fusiform amyloid deposits, histochemically and morphologically identical to those of lattice corneal dystrophy, are found in the deeper stroma. Additional features include recurrent corneal erosions, and glare and decreased night vision.</description>
<dbReference type="MIM" id="607541"/>
</disease>
<text>The disease is caused by mutations affecting the gene represented in this entry.</text>
</comment>
<comment type="similarity">
<text evidence="8">Contains 1 EMI domain.</text>
</comment>
<comment type="similarity">
<text evidence="7">Contains 4 FAS1 domains.</text>
</comment>
<comment type="online information" name="NIEHS-SNPs">
<link uri="http://egp.gs.washington.edu/data/tgfbi/"/>
</comment>
<comment type="online information" name="Atlas of Genetics and Cytogenetics in Oncology and Haematology">
<link uri="http://atlasgeneticsoncology.org/Genes/TGFBIID42539ch5q31.html"/>
</comment>
<dbReference type="EMBL" id="M77349">
<property type="protein sequence ID" value="AAA61163.1"/>
<property type="molecule type" value="mRNA"/>
</dbReference>
<dbReference type="EMBL" id="AF035626">
<property type="protein sequence ID" value="AAB88695.1"/>
<property type="molecule type" value="Genomic_DNA"/>
</dbReference>
<dbReference type="EMBL" id="AF035627">
<property type="protein sequence ID" value="AAB88698.1"/>
<property type="molecule type" value="Genomic_DNA"/>
</dbReference>
<dbReference type="EMBL" id="AF035628">
<property type="protein sequence ID" value="AAB88696.1"/>
<property type="molecule type" value="Genomic_DNA"/>
</dbReference>
<dbReference type="EMBL" id="AF035629">
<property type="protein sequence ID" value="AAB88697.1"/>
<property type="molecule type" value="Genomic_DNA"/>
</dbReference>
<dbReference type="EMBL" id="AY149344">
<property type="protein sequence ID" value="AAN10294.1"/>
<property type="molecule type" value="Genomic_DNA"/>
</dbReference>
<dbReference type="EMBL" id="BT009820">
<property type="protein sequence ID" value="AAP88822.1"/>
<property type="molecule type" value="mRNA"/>
</dbReference>
<dbReference type="EMBL" id="AC004503">
<property type="protein sequence ID" value="AAC08449.1"/>
<property type="molecule type" value="Genomic_DNA"/>
</dbReference>
<dbReference type="EMBL" id="AC005219">
<property type="protein sequence ID" value="AAC24944.1"/>
<property type="molecule type" value="Genomic_DNA"/>
</dbReference>
<dbReference type="EMBL" id="CH471062">
<property type="protein sequence ID" value="EAW62199.1"/>
<property type="molecule type" value="Genomic_DNA"/>
</dbReference>
<dbReference type="EMBL" id="CH471062">
<property type="protein sequence ID" value="EAW62200.1"/>
<property type="molecule type" value="Genomic_DNA"/>
</dbReference>
<dbReference type="EMBL" id="BC000097">
<property type="protein sequence ID" value="AAH00097.1"/>
<property type="molecule type" value="mRNA"/>
</dbReference>
<dbReference type="EMBL" id="BC004972">
<property type="protein sequence ID" value="AAH04972.1"/>
<property type="molecule type" value="mRNA"/>
</dbReference>
<dbReference type="CCDS" id="CCDS47266.1"/>
<dbReference type="PIR" id="I52996">
<property type="entry name" value="I52996"/>
</dbReference>
<dbReference type="RefSeq" id="NP_000349.1">
<property type="nucleotide sequence ID" value="NM_000358.2"/>
</dbReference>
<dbReference type="UniGene" id="Hs.369397"/>
<dbReference type="PDB" id="1X3B">
<property type="method" value="NMR"/>
<property type="chains" value="A=502-634"/>
</dbReference>
<dbReference type="PDB" id="2LTB">
<property type="method" value="NMR"/>
<property type="chains" value="A=502-634"/>
</dbReference>
<dbReference type="PDB" id="2LTC">
<property type="method" value="NMR"/>
<property type="chains" value="A=502-634"/>
</dbReference>
<dbReference type="PDB" id="2VXP">
<property type="method" value="X-ray"/>
<property type="resolution" value="2.50"/>
<property type="chains" value="A/B=502-633"/>
</dbReference>
<dbReference type="PDBsum" id="1X3B"/>
<dbReference type="PDBsum" id="2LTB"/>
<dbReference type="PDBsum" id="2LTC"/>
<dbReference type="PDBsum" id="2VXP"/>
<dbReference type="ProteinModelPortal" id="Q15582"/>
<dbReference type="SMR" id="Q15582">
<property type="residue range" value="124-235, 252-415, 502-634"/>
</dbReference>
<dbReference type="BioGrid" id="112903">
<property type="interactions" value="2"/>
</dbReference>
<dbReference type="IntAct" id="Q15582">
<property type="interactions" value="1"/>
</dbReference>
<dbReference type="MINT" id="MINT-122359"/>
<dbReference type="STRING" id="9606.ENSP00000416330"/>
<dbReference type="iPTMnet" id="Q15582"/>
<dbReference type="PhosphoSite" id="Q15582"/>
<dbReference type="BioMuta" id="TGFBI"/>
<dbReference type="DMDM" id="2498193"/>
<dbReference type="EPD" id="Q15582"/>
<dbReference type="MaxQB" id="Q15582"/>
<dbReference type="PaxDb" id="Q15582"/>
<dbReference type="PeptideAtlas" id="Q15582"/>
<dbReference type="PRIDE" id="Q15582"/>
<dbReference type="DNASU" id="7045"/>
<dbReference type="Ensembl" id="ENST00000442011">
<property type="protein sequence ID" value="ENSP00000416330"/>
<property type="gene ID" value="ENSG00000120708"/>
</dbReference>
<dbReference type="GeneID" id="7045"/>
<dbReference type="KEGG" id="hsa:7045"/>
<dbReference type="UCSC" id="uc003lbf.5">
<property type="organism name" value="human"/>
</dbReference>
<dbReference type="CTD" id="7045"/>
<dbReference type="GeneCards" id="TGFBI"/>
<dbReference type="HGNC" id="HGNC:11771">
<property type="gene designation" value="TGFBI"/>
</dbReference>
<dbReference type="HPA" id="HPA008612"/>
<dbReference type="HPA" id="HPA017019"/>
<dbReference type="MalaCards" id="TGFBI"/>
<dbReference type="MIM" id="121820">
<property type="type" value="phenotype"/>
</dbReference>
<dbReference type="MIM" id="121900">
<property type="type" value="phenotype"/>
</dbReference>
<dbReference type="MIM" id="122200">
<property type="type" value="phenotype"/>
</dbReference>
<dbReference type="MIM" id="601692">
<property type="type" value="gene"/>
</dbReference>
<dbReference type="MIM" id="602082">
<property type="type" value="phenotype"/>
</dbReference>
<dbReference type="MIM" id="607541">
<property type="type" value="phenotype"/>
</dbReference>
<dbReference type="MIM" id="608470">
<property type="type" value="phenotype"/>
</dbReference>
<dbReference type="MIM" id="608471">
<property type="type" value="phenotype"/>
</dbReference>
<dbReference type="neXtProt" id="NX_Q15582"/>
<dbReference type="Orphanet" id="98962">
<property type="disease" value="Granular corneal dystrophy type I"/>
</dbReference>
<dbReference type="Orphanet" id="98963">
<property type="disease" value="Granular corneal dystrophy type II"/>
</dbReference>
<dbReference type="Orphanet" id="98964">
<property type="disease" value="Lattice corneal dystrophy type I"/>
</dbReference>
<dbReference type="Orphanet" id="98956">
<property type="disease" value="Microcystic corneal dystrophy"/>
</dbReference>
<dbReference type="Orphanet" id="98961">
<property type="disease" value="Reis-Bucklers corneal dystrophy"/>
</dbReference>
<dbReference type="Orphanet" id="98960">
<property type="disease" value="Thiel-Behnke corneal dystrophy"/>
</dbReference>
<dbReference type="PharmGKB" id="PA36484"/>
<dbReference type="eggNOG" id="KOG1437">
<property type="taxonomic scope" value="Eukaryota"/>
</dbReference>
<dbReference type="eggNOG" id="COG2335">
<property type="taxonomic scope" value="LUCA"/>
</dbReference>
<dbReference type="GeneTree" id="ENSGT00530000063860"/>
<dbReference type="HOVERGEN" id="HBG000715"/>
<dbReference type="InParanoid" id="Q15582"/>
<dbReference type="KO" id="K19519"/>
<dbReference type="OMA" id="VITYECC"/>
<dbReference type="OrthoDB" id="EOG7N8ZV1"/>
<dbReference type="PhylomeDB" id="Q15582"/>
<dbReference type="TreeFam" id="TF316269"/>
<dbReference type="Reactome" id="R-HSA-977225">
<property type="pathway name" value="Amyloid fiber formation"/>
</dbReference>
<dbReference type="ChiTaRS" id="TGFBI">
<property type="organism name" value="human"/>
</dbReference>
<dbReference type="EvolutionaryTrace" id="Q15582"/>
<dbReference type="GeneWiki" id="TGFBI"/>
<dbReference type="GenomeRNAi" id="7045"/>
<dbReference type="NextBio" id="27529"/>
<dbReference type="PRO" id="PR:Q15582"/>
<dbReference type="Proteomes" id="UP000005640">
<property type="component" value="Chromosome 5"/>
</dbReference>
<dbReference type="Bgee" id="Q15582"/>
<dbReference type="CleanEx" id="HS_TGFBI"/>
<dbReference type="ExpressionAtlas" id="Q15582">
<property type="expression patterns" value="baseline and differential"/>
</dbReference>
<dbReference type="Genevisible" id="Q15582">
<property type="organism ID" value="HS"/>
</dbReference>
<dbReference type="GO" id="GO:0005604">
<property type="term" value="C:basement membrane"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="Ensembl"/>
</dbReference>
<dbReference type="GO" id="GO:0070062">
<property type="term" value="C:extracellular exosome"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0005576">
<property type="term" value="C:extracellular region"/>
<property type="evidence" value="ECO:0000304"/>
<property type="project" value="Reactome"/>
</dbReference>
<dbReference type="GO" id="GO:0005615">
<property type="term" value="C:extracellular space"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="BHF-UCL"/>
</dbReference>
<dbReference type="GO" id="GO:0005886">
<property type="term" value="C:plasma membrane"/>
<property type="evidence" value="ECO:0000304"/>
<property type="project" value="Reactome"/>
</dbReference>
<dbReference type="GO" id="GO:0005578">
<property type="term" value="C:proteinaceous extracellular matrix"/>
<property type="evidence" value="ECO:0000318"/>
<property type="project" value="GO_Central"/>
</dbReference>
<dbReference type="GO" id="GO:0005802">
<property type="term" value="C:trans-Golgi network"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="BHF-UCL"/>
</dbReference>
<dbReference type="GO" id="GO:0005518">
<property type="term" value="F:collagen binding"/>
<property type="evidence" value="ECO:0000353"/>
<property type="project" value="BHF-UCL"/>
</dbReference>
<dbReference type="GO" id="GO:0050840">
<property type="term" value="F:extracellular matrix binding"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="Ensembl"/>
</dbReference>
<dbReference type="GO" id="GO:0005178">
<property type="term" value="F:integrin binding"/>
<property type="evidence" value="ECO:0000304"/>
<property type="project" value="ProtInc"/>
</dbReference>
<dbReference type="GO" id="GO:0001525">
<property type="term" value="P:angiogenesis"/>
<property type="evidence" value="ECO:0000270"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0007155">
<property type="term" value="P:cell adhesion"/>
<property type="evidence" value="ECO:0000318"/>
<property type="project" value="GO_Central"/>
</dbReference>
<dbReference type="GO" id="GO:0008283">
<property type="term" value="P:cell proliferation"/>
<property type="evidence" value="ECO:0000304"/>
<property type="project" value="ProtInc"/>
</dbReference>
<dbReference type="GO" id="GO:0044267">
<property type="term" value="P:cellular protein metabolic process"/>
<property type="evidence" value="ECO:0000304"/>
<property type="project" value="Reactome"/>
</dbReference>
<dbReference type="GO" id="GO:0002062">
<property type="term" value="P:chondrocyte differentiation"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="Ensembl"/>
</dbReference>
<dbReference type="GO" id="GO:0030198">
<property type="term" value="P:extracellular matrix organization"/>
<property type="evidence" value="ECO:0000318"/>
<property type="project" value="GO_Central"/>
</dbReference>
<dbReference type="GO" id="GO:0007162">
<property type="term" value="P:negative regulation of cell adhesion"/>
<property type="evidence" value="ECO:0000304"/>
<property type="project" value="ProtInc"/>
</dbReference>
<dbReference type="GO" id="GO:0050896">
<property type="term" value="P:response to stimulus"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="UniProtKB-KW"/>
</dbReference>
<dbReference type="GO" id="GO:0007601">
<property type="term" value="P:visual perception"/>
<property type="evidence" value="ECO:0000304"/>
<property type="project" value="ProtInc"/>
</dbReference>
<dbReference type="Gene3D" id="2.30.180.10">
<property type="match status" value="4"/>
</dbReference>
<dbReference type="InterPro" id="IPR011489">
<property type="entry name" value="EMI_domain"/>
</dbReference>
<dbReference type="InterPro" id="IPR000782">
<property type="entry name" value="FAS1_domain"/>
</dbReference>
<dbReference type="InterPro" id="IPR032954">
<property type="entry name" value="TGFBI"/>
</dbReference>
<dbReference type="InterPro" id="IPR016666">
<property type="entry name" value="TGFBI/POSTN"/>
</dbReference>
<dbReference type="PANTHER" id="PTHR10900:SF82">
<property type="entry name" value="PTHR10900:SF82"/>
<property type="match status" value="2"/>
</dbReference>
<dbReference type="Pfam" id="PF02469">
<property type="entry name" value="Fasciclin"/>
<property type="match status" value="4"/>
</dbReference>
<dbReference type="PIRSF" id="PIRSF016553">
<property type="entry name" value="BIGH3_OSF2"/>
<property type="match status" value="1"/>
</dbReference>
<dbReference type="SMART" id="SM00554">
<property type="entry name" value="FAS1"/>
<property type="match status" value="4"/>
</dbReference>
<dbReference type="SUPFAM" id="SSF82153">
<property type="entry name" value="SSF82153"/>
<property type="match status" value="4"/>
</dbReference>
<dbReference type="PROSITE" id="PS51041">
<property type="entry name" value="EMI"/>
<property type="match status" value="1"/>
</dbReference>
<dbReference type="PROSITE" id="PS50213">
<property type="entry name" value="FAS1"/>
<property type="match status" value="4"/>
</dbReference>
<proteinExistence type="evidence at protein level"/>
<keyword id="KW-0002">3D-structure</keyword>
<keyword id="KW-0034">Amyloid</keyword>
<keyword id="KW-1008">Amyloidosis</keyword>
<keyword id="KW-0130">Cell adhesion</keyword>
<keyword id="KW-0181">Complete proteome</keyword>
<keyword id="KW-1212">Corneal dystrophy</keyword>
<keyword id="KW-0225">Disease mutation</keyword>
<keyword id="KW-1015">Disulfide bond</keyword>
<keyword id="KW-0272">Extracellular matrix</keyword>
<keyword id="KW-0301">Gamma-carboxyglutamic acid</keyword>
<keyword id="KW-0597">Phosphoprotein</keyword>
<keyword id="KW-0621">Polymorphism</keyword>
<keyword id="KW-1185">Reference proteome</keyword>
<keyword id="KW-0677">Repeat</keyword>
<keyword id="KW-0964">Secreted</keyword>
<keyword id="KW-0716">Sensory transduction</keyword>
<keyword id="KW-0732">Signal</keyword>
<keyword id="KW-0844">Vision</keyword>
<feature type="signal peptide" evidence="5">
<location>
<begin position="1"/>
<end position="23"/>
</location>
</feature>
<feature type="chain" description="Transforming growth factor-beta-induced protein ig-h3" id="PRO_0000008769">
<location>
<begin position="24"/>
<end position="683"/>
</location>
</feature>
<feature type="domain" description="EMI" evidence="8">
<location>
<begin position="45"/>
<end position="99"/>
</location>
</feature>
<feature type="domain" description="FAS1 1" evidence="7">
<location>
<begin position="103"/>
<end position="236"/>
</location>
</feature>
<feature type="domain" description="FAS1 2" evidence="7">
<location>
<begin position="240"/>
<end position="371"/>
</location>
</feature>
<feature type="domain" description="FAS1 3" evidence="7">
<location>
<begin position="375"/>
<end position="498"/>
</location>
</feature>
<feature type="domain" description="FAS1 4" evidence="7">
<location>
<begin position="502"/>
<end position="632"/>
</location>
</feature>
<feature type="short sequence motif" description="Cell attachment site" evidence="6">
<location>
<begin position="642"/>
<end position="644"/>
</location>
</feature>
<feature type="modified residue" description="Phosphoserine" evidence="4">
<location>
<position position="37"/>
</location>
</feature>
<feature type="modified residue" description="4-carboxyglutamate" evidence="6">
<location>
<position position="108"/>
</location>
</feature>
<feature type="modified residue" description="4-carboxyglutamate" evidence="6">
<location>
<position position="126"/>
</location>
</feature>
<feature type="modified residue" description="4-carboxyglutamate" evidence="6">
<location>
<position position="131"/>
</location>
</feature>
<feature type="modified residue" description="4-carboxyglutamate" evidence="6">
<location>
<position position="133"/>
</location>
</feature>
<feature type="modified residue" description="4-carboxyglutamate" evidence="6">
<location>
<position position="146"/>
</location>
</feature>
<feature type="modified residue" description="4-carboxyglutamate" evidence="6">
<location>
<position position="154"/>
</location>
</feature>
<feature type="modified residue" description="4-carboxyglutamate" evidence="6">
<location>
<position position="166"/>
</location>
</feature>
<feature type="modified residue" description="4-carboxyglutamate" evidence="6">
<location>
<position position="184"/>
</location>
</feature>
<feature type="modified residue" description="4-carboxyglutamate" evidence="6">
<location>
<position position="248"/>
</location>
</feature>
<feature type="modified residue" description="4-carboxyglutamate" evidence="6">
<location>
<position position="250"/>
</location>
</feature>
<feature type="modified residue" description="4-carboxyglutamate" evidence="6">
<location>
<position position="254"/>
</location>
</feature>
<feature type="modified residue" description="4-carboxyglutamate" evidence="6">
<location>
<position position="270"/>
</location>
</feature>
<feature type="modified residue" description="4-carboxyglutamate" evidence="6">
<location>
<position position="283"/>
</location>
</feature>
<feature type="modified residue" description="4-carboxyglutamate" evidence="6">
<location>
<position position="286"/>
</location>
</feature>
<feature type="modified residue" description="4-carboxyglutamate" evidence="6">
<location>
<position position="291"/>
</location>
</feature>
<feature type="modified residue" description="4-carboxyglutamate" evidence="6">
<location>
<position position="301"/>
</location>
</feature>
<feature type="modified residue" description="4-carboxyglutamate" evidence="6">
<location>
<position position="319"/>
</location>
</feature>
<feature type="modified residue" description="4-carboxyglutamate" evidence="6">
<location>
<position position="328"/>
</location>
</feature>
<feature type="modified residue" description="4-carboxyglutamate" evidence="6">
<location>
<position position="331"/>
</location>
</feature>
<feature type="modified residue" description="4-carboxyglutamate" evidence="6">
<location>
<position position="336"/>
</location>
</feature>
<feature type="modified residue" description="4-carboxyglutamate" evidence="6">
<location>
<position position="529"/>
</location>
</feature>
<feature type="modified residue" description="4-carboxyglutamate" evidence="6">
<location>
<position position="534"/>
</location>
</feature>
<feature type="modified residue" description="4-carboxyglutamate" evidence="6">
<location>
<position position="545"/>
</location>
</feature>
<feature type="modified residue" description="4-carboxyglutamate" evidence="6">
<location>
<position position="554"/>
</location>
</feature>
<feature type="modified residue" description="4-carboxyglutamate" evidence="6">
<location>
<position position="564"/>
</location>
</feature>
<feature type="modified residue" description="4-carboxyglutamate" evidence="6">
<location>
<position position="576"/>
</location>
</feature>
<feature type="modified residue" description="4-carboxyglutamate" evidence="6">
<location>
<position position="598"/>
</location>
</feature>
<feature type="modified residue" description="4-carboxyglutamate" evidence="6">
<location>
<position position="611"/>
</location>
</feature>
<feature type="modified residue" description="4-carboxyglutamate" evidence="6">
<location>
<position position="615"/>
</location>
</feature>
<feature type="disulfide bond" evidence="8">
<location>
<begin position="49"/>
<end position="85"/>
</location>
</feature>
<feature type="disulfide bond" evidence="8">
<location>
<begin position="65"/>
<end position="74"/>
</location>
</feature>
<feature type="disulfide bond" evidence="8">
<location>
<begin position="84"/>
<end position="97"/>
</location>
</feature>
<feature type="sequence variant" description="In granular corneal dystrophy; unclassified form; with centrifuge pattern of opacities." id="VAR_031531" evidence="25">
<original>V</original>
<variation>I</variation>
<location>
<position position="113"/>
</location>
</feature>
<feature type="sequence variant" description="In granular corneal dystrophy; unclassified form; Hanoi; dbSNP:rs541270955." id="VAR_031532" evidence="18">
<original>D</original>
<variation>H</variation>
<location>
<position position="123"/>
</location>
</feature>
<feature type="sequence variant" description="In CDL1." id="VAR_005076" evidence="14 15 17 21 29 30">
<original>R</original>
<variation>C</variation>
<location>
<position position="124"/>
</location>
</feature>
<feature type="sequence variant" description="In CDA; most common mutation in Japanese." id="VAR_005077" evidence="10 14 15 17 29 30">
<original>R</original>
<variation>H</variation>
<location>
<position position="124"/>
</location>
</feature>
<feature type="sequence variant" description="In CDRB." id="VAR_005078" evidence="13 14 15 21 32">
<original>R</original>
<variation>L</variation>
<location>
<position position="124"/>
</location>
</feature>
<feature type="sequence variant" description="In CDGG1; late-onset; mild ocular irritation and reduction in visual acuity." id="VAR_012444" evidence="10 17">
<original>R</original>
<variation>S</variation>
<location>
<position position="124"/>
</location>
</feature>
<feature type="sequence variant" description="Associated with Leu-124 in atypical granular dystrophy; French granular variant." id="VAR_012445" evidence="13 15">
<location>
<begin position="125"/>
<end position="126"/>
</location>
</feature>
<feature type="sequence variant" description="In dbSNP:rs45455404." id="VAR_014335" evidence="34">
<original>I</original>
<variation>F</variation>
<location>
<position position="200"/>
</location>
</feature>
<feature type="sequence variant" description="In dbSNP:rs199852470." id="VAR_031533" evidence="21">
<original>L</original>
<variation>F</variation>
<location>
<position position="269"/>
</location>
</feature>
<feature type="sequence variant" description="In dbSNP:rs10057190." id="VAR_031534">
<original>R</original>
<variation>G</variation>
<location>
<position position="496"/>
</location>
</feature>
<feature type="sequence variant" description="In CDL3A; dbSNP:rs121909212." id="VAR_005079" evidence="14 31">
<original>P</original>
<variation>T</variation>
<location>
<position position="501"/>
</location>
</feature>
<feature type="sequence variant" description="In CDL1." id="VAR_031535" evidence="23">
<original>V</original>
<variation>D</variation>
<location>
<position position="505"/>
</location>
</feature>
<feature type="sequence variant" description="In EBMD." id="VAR_031536" evidence="26">
<original>L</original>
<variation>R</variation>
<location>
<position position="509"/>
</location>
</feature>
<feature type="sequence variant" description="In CDL1." id="VAR_012446" evidence="12">
<original>L</original>
<variation>P</variation>
<location>
<position position="518"/>
</location>
</feature>
<feature type="sequence variant" description="In CDL1; severe phenotype; delayed age of onset." id="VAR_018484" evidence="17">
<original>L</original>
<variation>R</variation>
<location>
<position position="518"/>
</location>
</feature>
<feature type="sequence variant" description="In CDL1; late-onset; found also in sporadic cases." id="VAR_005080" evidence="14 16 33">
<original>L</original>
<variation>R</variation>
<location>
<position position="527"/>
</location>
</feature>
<feature type="sequence variant" description="In CDL1; delayed age of onset." id="VAR_018485" evidence="17">
<original>T</original>
<variation>R</variation>
<location>
<position position="538"/>
</location>
</feature>
<feature type="sequence variant" description="In lattice corneal dystrophy; unclassified form." id="VAR_031537" evidence="21">
<original>V</original>
<variation>D</variation>
<location>
<position position="539"/>
</location>
</feature>
<feature type="sequence variant" description="In CDL3A." id="VAR_031538" evidence="22">
<original>F</original>
<variation>S</variation>
<location>
<position position="540"/>
</location>
</feature>
<feature type="sequence variant" description="In CDRB." id="VAR_005081" evidence="11 17">
<location>
<position position="540"/>
</location>
</feature>
<feature type="sequence variant" description="In CDL; late-onset." id="VAR_012447" evidence="14">
<original>N</original>
<variation>S</variation>
<location>
<position position="544"/>
</location>
</feature>
<feature type="sequence variant" description="In CDL1; associated with Q-551." id="VAR_031539" evidence="20">
<original>A</original>
<variation>D</variation>
<location>
<position position="546"/>
</location>
</feature>
<feature type="sequence variant" description="In CDL3A." id="VAR_012448" evidence="15">
<original>A</original>
<variation>T</variation>
<location>
<position position="546"/>
</location>
</feature>
<feature type="sequence variant" description="In CDL1; associated with D-546." id="VAR_031540" evidence="20">
<original>P</original>
<variation>Q</variation>
<location>
<position position="551"/>
</location>
</feature>
<feature type="sequence variant" description="In CDTB; originally thought to cause CDRB." id="VAR_005082" evidence="14 15 29 30">
<original>R</original>
<variation>Q</variation>
<location>
<position position="555"/>
</location>
</feature>
<feature type="sequence variant" description="In CDGG1; common mutation in Europe and United States; rare in Japan." id="VAR_005083" evidence="10 14 15 17 21 29 30">
<original>R</original>
<variation>W</variation>
<location>
<position position="555"/>
</location>
</feature>
<feature type="sequence variant" description="In CDL1." id="VAR_031541" evidence="19">
<original>L</original>
<variation>R</variation>
<location>
<position position="569"/>
</location>
</feature>
<feature type="sequence variant" description="In CDL1; late-onset." id="VAR_031543" evidence="27">
<original>H</original>
<variation>R</variation>
<location>
<position position="572"/>
</location>
</feature>
<feature type="sequence variant" description="In CDL1; late-onset and unilateral phenotype." id="VAR_031542" evidence="24">
<location>
<position position="572"/>
</location>
</feature>
<feature type="sequence variant" description="In lattice corneal dystrophy; unclassified form." id="VAR_031544" evidence="21">
<original>G</original>
<variation>V</variation>
<location>
<position position="594"/>
</location>
</feature>
<feature type="sequence variant" description="In asymmetric lattice corneal dystrophy." id="VAR_012449" evidence="9">
<original>N</original>
<variation>H</variation>
<location>
<position position="622"/>
</location>
</feature>
<feature type="sequence variant" description="In CDL3A." id="VAR_018486" evidence="17">
<original>N</original>
<variation>K</variation>
<location>
<position position="622"/>
</location>
</feature>
<feature type="sequence variant" description="In CDL1; delayed age of onset." id="VAR_018487" evidence="17">
<original>G</original>
<variation>D</variation>
<location>
<position position="623"/>
</location>
</feature>
<feature type="sequence variant" description="In lattice corneal dystrophy; unclassified form." id="VAR_031545" evidence="21">
<location>
<begin position="624"/>
<end position="625"/>
</location>
</feature>
<feature type="sequence variant" description="In CDL1." id="VAR_018488" evidence="17">
<original>H</original>
<variation>P</variation>
<location>
<position position="626"/>
</location>
</feature>
<feature type="sequence variant" description="In CDL1; delayed age of onset." id="VAR_012450" evidence="9 15 17 21">
<original>H</original>
<variation>R</variation>
<location>
<position position="626"/>
</location>
</feature>
<feature type="sequence variant" description="In CDL." id="VAR_018489" evidence="17">
<original>V</original>
<variation>D</variation>
<location>
<position position="631"/>
</location>
</feature>
<feature type="sequence variant" description="In EBMD; low penetrance in one family; dbSNP:rs121909217." id="VAR_031546" evidence="26">
<original>R</original>
<variation>S</variation>
<location>
<position position="666"/>
</location>
</feature>
<feature type="helix" evidence="3">
<location>
<begin position="505"/>
<end position="509"/>
</location>
</feature>
<feature type="strand" evidence="2">
<location>
<begin position="512"/>
<end position="515"/>
</location>
</feature>
<feature type="helix" evidence="3">
<location>
<begin position="516"/>
<end position="525"/>
</location>
</feature>
<feature type="helix" evidence="3">
<location>
<begin position="528"/>
<end position="532"/>
</location>
</feature>
<feature type="strand" evidence="1">
<location>
<begin position="533"/>
<end position="535"/>
</location>
</feature>
<feature type="strand" evidence="3">
<location>
<begin position="537"/>
<end position="542"/>
</location>
</feature>
<feature type="helix" evidence="3">
<location>
<begin position="544"/>
<end position="549"/>
</location>
</feature>
<feature type="helix" evidence="3">
<location>
<begin position="552"/>
<end position="559"/>
</location>
</feature>
<feature type="helix" evidence="3">
<location>
<begin position="562"/>
<end position="571"/>
</location>
</feature>
<feature type="strand" evidence="3">
<location>
<begin position="572"/>
<end position="576"/>
</location>
</feature>
<feature type="helix" evidence="2">
<location>
<begin position="580"/>
<end position="583"/>
</location>
</feature>
<feature type="strand" evidence="3">
<location>
<begin position="587"/>
<end position="591"/>
</location>
</feature>
<feature type="strand" evidence="3">
<location>
<begin position="594"/>
<end position="602"/>
</location>
</feature>
<feature type="strand" evidence="3">
<location>
<begin position="605"/>
<end position="610"/>
</location>
</feature>
<feature type="strand" evidence="3">
<location>
<begin position="614"/>
<end position="620"/>
</location>
</feature>
<feature type="strand" evidence="3">
<location>
<begin position="623"/>
<end position="630"/>
</location>
</feature>
<evidence key="1" type="ECO:0000244">
<source>
<dbReference type="PDB" id="1X3B"/>
</source>
</evidence>
<evidence key="2" type="ECO:0000244">
<source>
<dbReference type="PDB" id="2LTB"/>
</source>
</evidence>
<evidence key="3" type="ECO:0000244">
<source>
<dbReference type="PDB" id="2VXP"/>
</source>
</evidence>
<evidence key="4" type="ECO:0000244">
<source>
<dbReference type="PubMed" id="24275569"/>
</source>
</evidence>
<evidence key="5" type="ECO:0000250"/>
<evidence key="6" type="ECO:0000255"/>
<evidence key="7" type="ECO:0000255">
<source>
<dbReference type="PROSITE-ProRule" id="PRU00082"/>
</source>
</evidence>
<evidence key="8" type="ECO:0000255">
<source>
<dbReference type="PROSITE-ProRule" id="PRU00384"/>
</source>
</evidence>
<evidence key="9" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="10328397"/>
</source>
</evidence>
<evidence key="10" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="10425035"/>
</source>
</evidence>
<evidence key="11" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="10660331"/>
</source>
</evidence>
<evidence key="12" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="10837380"/>
</source>
</evidence>
<evidence key="13" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="10865320"/>
</source>
</evidence>
<evidence key="14" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="11024425"/>
</source>
</evidence>
<evidence key="15" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="11297504"/>
</source>
</evidence>
<evidence key="16" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="11413411"/>
</source>
</evidence>
<evidence key="17" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="11923233"/>
</source>
</evidence>
<evidence key="18" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="12782158"/>
</source>
</evidence>
<evidence key="19" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="14597039"/>
</source>
</evidence>
<evidence key="20" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="15531312"/>
</source>
</evidence>
<evidence key="21" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="15623763"/>
</source>
</evidence>
<evidence key="22" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="15790870"/>
</source>
</evidence>
<evidence key="23" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="15838722"/>
</source>
</evidence>
<evidence key="24" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="16541014"/>
</source>
</evidence>
<evidence key="25" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="16636649"/>
</source>
</evidence>
<evidence key="26" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="16652336"/>
</source>
</evidence>
<evidence key="27" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="17013691"/>
</source>
</evidence>
<evidence key="28" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="8077289"/>
</source>
</evidence>
<evidence key="29" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="9054935"/>
</source>
</evidence>
<evidence key="30" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="9463327"/>
</source>
</evidence>
<evidence key="31" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="9497262"/>
</source>
</evidence>
<evidence key="32" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="9780098"/>
</source>
</evidence>
<evidence key="33" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="9799082"/>
</source>
</evidence>
<evidence key="34" type="ECO:0000269">
<source ref="3"/>
</evidence>
<sequence length="683" mass="74681" checksum="40FDC8A71EBB3D00" modified="1996-11-01" version="1" precursor="true">
MALFVRLLALALALALGPAATLAGPAKSPYQLVLQHSRLRGRQHGPNVCAVQKVIGTNRK
YFTNCKQWYQRKICGKSTVISYECCPGYEKVPGEKGCPAALPLSNLYETLGVVGSTTTQL
YTDRTEKLRPEMEGPGSFTIFAPSNEAWASLPAEVLDSLVSNVNIELLNALRYHMVGRRV
LTDELKHGMTLTSMYQNSNIQIHHYPNGIVTVNCARLLKADHHATNGVVHLIDKVISTIT
NNIQQIIEIEDTFETLRAAVAASGLNTMLEGNGQYTLLAPTNEAFEKIPSETLNRILGDP
EALRDLLNNHILKSAMCAEAIVAGLSVETLEGTTLEVGCSGDMLTINGKAIISNKDILAT
NGVIHYIDELLIPDSAKTLFELAAESDVSTAIDLFRQAGLGNHLSGSERLTLLAPLNSVF
KDGTPPIDAHTRNLLRNHIIKDQLASKYLYHGQTLETLGGKKLRVFVYRNSLCIENSCIA
AHDKRGRYGTLFTMDRVLTPPMGTVMDVLKGDNRFSMLVAAIQSAGLTETLNREGVYTVF
APTNEAFRALPPRERSRLLGDAKELANILKYHIGDEILVSGGIGALVRLKSLQGDKLEVS
LKNNVVSVNKEPVAEPDIMATNGVVHVITNVLQPPANRPQERGDELADSALEIFKQASAF
SRASQRSVRLAPVYQKLLERMKH
</sequence>
</entry>
<copyright>
Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
Distributed under the Creative Commons Attribution-NoDerivs License
</copyright>
</uniprot>